GB202211117D0 - Compositions and methods for non-immunogenecity - Google Patents

Compositions and methods for non-immunogenecity

Info

Publication number
GB202211117D0
GB202211117D0 GBGB2211117.3A GB202211117A GB202211117D0 GB 202211117 D0 GB202211117 D0 GB 202211117D0 GB 202211117 A GB202211117 A GB 202211117A GB 202211117 D0 GB202211117 D0 GB 202211117D0
Authority
GB
United Kingdom
Prior art keywords
immunogenecity
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2211117.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replay Holdings Inc
Original Assignee
Replay Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replay Holdings Inc filed Critical Replay Holdings Inc
Priority to GBGB2211117.3A priority Critical patent/GB202211117D0/en
Publication of GB202211117D0 publication Critical patent/GB202211117D0/en
Priority to PCT/US2023/071272 priority patent/WO2024026495A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2211117.3A 2022-07-29 2022-07-29 Compositions and methods for non-immunogenecity Ceased GB202211117D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2211117.3A GB202211117D0 (en) 2022-07-29 2022-07-29 Compositions and methods for non-immunogenecity
PCT/US2023/071272 WO2024026495A1 (en) 2022-07-29 2023-07-28 Compositions and methods for non-immunogenicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2211117.3A GB202211117D0 (en) 2022-07-29 2022-07-29 Compositions and methods for non-immunogenecity

Publications (1)

Publication Number Publication Date
GB202211117D0 true GB202211117D0 (en) 2022-09-14

Family

ID=84540618

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2211117.3A Ceased GB202211117D0 (en) 2022-07-29 2022-07-29 Compositions and methods for non-immunogenecity

Country Status (2)

Country Link
GB (1) GB202211117D0 (en)
WO (1) WO2024026495A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000677A1 (en) * 2000-06-07 2002-01-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CA2469941A1 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
EP3294342A4 (en) * 2015-05-08 2018-11-07 President and Fellows of Harvard College Universal donor stem cells and related methods
US20190376045A1 (en) * 2017-01-13 2019-12-12 The Regents Of The University Of California Immunoengineered pluripotent cells
KR20230074718A (en) * 2020-08-13 2023-05-31 사나 바이오테크놀로지, 인크. Methods of treating patients sensitized with hypoimmunogenic cells and related methods and compositions

Also Published As

Publication number Publication date
WO2024026495A1 (en) 2024-02-01

Similar Documents

Publication Publication Date Title
GB202111040D0 (en) Compositions and methods
EP4138879A4 (en) Methods and compositions
EP4084784A4 (en) Compositions and methods
GB202004677D0 (en) Methods and compositions
IL308402A (en) Methods and compositions for radioprotection
GB202110091D0 (en) Methods and compositions
GB202211117D0 (en) Compositions and methods for non-immunogenecity
GB202316106D0 (en) Methods and compositions
GB202316109D0 (en) Methods and compositions
GB202311858D0 (en) Methods and compositions
GB202308901D0 (en) Methods and compositions
GB202307563D0 (en) Methods and compositions
GB202305427D0 (en) Methods and compositions
GB202304240D0 (en) Compositions and methods
GB202219851D0 (en) Compositions and methods
GB202209588D0 (en) Methods and compositions
GB202209115D0 (en) Compositions and methods
GB202206268D0 (en) Compositions and methods
GB202205579D0 (en) Methods and compositions
GB202306393D0 (en) Trna-based methods and related compositions
GB202217944D0 (en) Compositions and method
GB202307390D0 (en) Compositions and methods and uses related thereto
GB202310301D0 (en) Compositions and method and uses related thereto
GB202316199D0 (en) Compositions and methods and uses thereto
IL304824A (en) Fospropofol methods and compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)